cGxP.wire https://validator.w3.org/feed/docs/rss2.html EnteroBiotix Secures £19M for Phase 2b IBS-C Trial Alcresta Therapeutics Shows RELiZORBneo Benefit Data Viatris Low-Dose Estrogen Patch Phase 3 Data Update LEO Pharma Acquires Replay to Boost Gene Therapy Guardant Health, Nuvalent Partner in Precision Oncology Sydnexis, Inc. Advances SYD-101 Data in Myopia Trial Larimar Therapeutics Validates Skin Biomarker in FA Apotex Gains Canada Approval for Generic Ozempic Contineum Therapeutics Reports Positive PIPE-791 Data Keenova TERLIVAZ Real-World Data Advances HRS-AKI Care Zeta Surgical Wins FDA Clearance for Neuro Navigation Corcept Therapeutics Reports ALS Survival Breakthrough Diakonos Oncology Reports Phase 1 DOC1021 Survival Data MRM Health Launches Phase 2b UC Trial with MH002 AstraZeneca TRUQAP Gains FDA Panel Support in Prostate Cancer Bambusa Therapeutics Completes BBT001 Trial Enrollment SetPoint Medical Starts MS Study for Neuroimmune Therapy BeOne Medicines Gains FDA Priority Review for TEVIMBRA Kernal Biologics Showcases mRNA 2.0 CAR-T Platform Neurocrine Defines TDIS Threshold for TD Treatment Impact Iterative Health Secures $77M to Accelerate Clinical Trials Huahui Health, BeOne Strike $2B HH160 Oncology Deal Made Scientific Expands Board for Cell Therapy Scale-Up OS Therapies Secures EMA Review for OST-HER2 Drug Theradaptive Gains FDA Approval for Regenerative Spine Therapy AC Immune Advances ACI-24 Alzheimer’s Trial Expansion Century Therapeutics Highlights CNTY-813 Data at ADA AVITA Medical Secures TGA Approval for RECELL GO in Australia Immunome Files FDA NDA for Varegacestat in Tumors Paradigm Health, FDA Advance Real-Time Trial Review Model Renibus Reports Phase 3 RBT-1 Data at AATS Meeting Novo Nordisk Reports Strong Phase 3 Results for Denecimig in Hemophilia A TRexBio Advances TRB-061 Phase 1b Trial for Atopic Dermatitis Pharmascience Launches pms-DOLUTEGRAVIR in Canada Cocrystal Pharma Advances CDI-988 for Norovirus Care Aidoc Secures $150M Led by Goldman Sachs for AI Growth Earflo Wins FDA Clearance for Pediatric Ear Device EnGeneIC Doses First Patient in GBM EDV Therapy Trial Telix Advances TLX597-Tx Phase 2 Prostate Cancer Program Olympus Gains FDA Clearance for POWERSEAL Open Device Profluent, Lilly Partner to Advance AI Gene Editing Tech PreludeDx Secures FDA Breakthrough for AidaBREAST Test Mesoblast Completes Enrollment in Pivotal Phase 3 Trial for Chronic Low Back Pain Kestrel Therapeutics Doses First Patient in KRAS Trial CareDx Acquires Naveris to Expand Precision Oncology InnoCare Advances Phase III Orelabrutinib Trial for SLE Chiesi to Acquire KalVista in $1.9B Rare Disease Deal Axsome Therapeutics Secures FDA Approval for AUVELITY in Alzheimer’s Agitation IDEAYA Advances NDA for Darovasertib Under FDA RTOR Laguna Gains FDA IND Clearance for LGNA-100 Therapy